September 20, 2017 — Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the ...
September 20, 2017
September 19, 2017 — ScImage Inc. and Invia Imaging Solutions recently announced formation of a joint partnership at the ...
September 19, 2017
Feature | Nuclear Imaging | Dave Fornell
Cardiac nuclear myocardial perfusion imaging (MPI) has been a mature area of imaging for years, but has recently started ...
September 19, 2017
September 18, 2017 — Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU ...
September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the Journal of the American College of ...
September 18, 2017
September 15, 2017 — Philips highlighted its newest solution for nuclear cardiology, CardioMD IV, at the American ...
September 15, 2017
September 14, 2017 — Marijuana use is associated with a three-fold risk of death from hypertension, according to ...
September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials ...
September 14, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Sidra ...
September 13, 2017
September 13, 2017 — Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference ...
September 13, 2017
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
September 13, 2017 — A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results ...
September 13, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, according ...
September 12, 2017September 12, 2017 — Inclisiran lowers low-density lipoprotein (LDL, or “bad”) cholesterol for up to one year in ...
September 12, 2017
September 12, 2017 — Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with progressively ...
September 12, 2017
September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by ...
September 12, 2017